Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?

Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?

Zobrazit další vydání (1)

Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of moderate to severe acute pain in adult patients. The...

Celý popis

Podrobná bibliografie
Hlavní autoři: Montserrat Viñas-Bastart, Míriam Oms-Arias, Àfrica Pedraza-Gutiérrez, Irene Lizano-Díez, Eduardo L. Mariño, Pilar Modamio Charles
Médium: Článek
Jazyk:English
Vydáno: Fundación Pharmaceutical Care España 2022-06-01
Edice:Pharmaceutical Care España
Témata:
Off-label use; opioid; pharmacoepidemiology; primary health care; tramadol/dexketoprofen; drug combinations
On-line přístup:https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680

Internet

https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680

Podobné jednotky